Rivastigmine for ECT-induced cognitive adverse effects in late life depression (RECALL study): A multicenter, randomized, double blind, placebo-controlled, cross-over trial in pati...

por Henstra, Marieke J., Feenstra, Thomas C., Kok, Rob M., Spaans, Harm-Pieter, van Exel, Eric, Dols, Annemiek, Oudega, Mardien, Vergouwen, Anton C. M., van der Loo, Adriano, Bet, Pierre M., Loer, Stephan A., Eikelenboom, Merijn, Sienaert, Pascal, Lambrichts, Simon, Bouckaert, Filip, Bosmans, Judith E., van der Velde, Nathalie, Beekman, Aartjan T. F., Stek, Max L., Rhebergen, Didi
Publicado 2022